Client Communications - Prime Therapeutics

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Client Communication
Client Communications

Explore what's trending at Prime

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms Example Link

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-prime-s-response-to-recent-aids-healthcare-foundation-ruling Example Link

Client news

READ: Prime’s response to recent AIDS Healthcare Foundation ruling

January 27, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1 Example Link

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-1 Example Link

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

The Latest

Categories

CC Health Plans

https://primetherapeutics.com/w/read-prime-s-response-to-recent-aids-healthcare-foundation-ruling

Client news

READ: Prime’s response to recent AIDS Healthcare Foundation ruling

January 27, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 16, 2025

https://primetherapeutics.com/w/read-ira-faq-updates-january-2025

Client news

READ: IRA FAQ updates - January 2025

January 15, 2025

https://primetherapeutics.com/w/read-improved-contact-center-performance-this-week-1

Client news

READ: Improved contact center performance this week

January 10, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms-1-1

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/read-stars-and-bid-forum-prime-s-medicare-clients-lead-the-way-1

Client news

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

December 19, 2024

Showing 1 to 9 of 71

Categories

CC Mid-Market Accounts

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 16, 2025

https://primetherapeutics.com/w/updates-to-glp-1s-and-maintenance-indicator-for-mid-market-clients

Client news

Updates to GLP-1s and Prime's standard maintenance drug list used by mid-market clients

January 08, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

https://primetherapeutics.com/w/read-prime-s-glp-1-resources-page-prime-s-source-for-everything-glp-1

Client news

READ: Prime’s GLP-1 resources page: Prime’s source for everything GLP-1

November 18, 2024

Showing 1 to 9 of 35

Categories

CC National Accounts

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

https://primetherapeutics.com/w/read-prime-s-glp-1-resources-page-prime-s-source-for-everything-glp-1

Client news

READ: Prime’s GLP-1 resources page: Prime’s source for everything GLP-1

November 18, 2024

https://primetherapeutics.com/w/read-new-prime-brand-update-1

Client news

READ: New Prime brand update

November 07, 2024

Showing 1 to 9 of 57

Categories

CC Medical Pharmacy / Specialty

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

https://primetherapeutics.com/w/read-mandatory-sensitivity-labels-begin-nov-14-1

Client news

READ: Mandatory sensitivity labels begin Nov. 14

November 04, 2024

https://primetherapeutics.com/w/read-follow-up-to-second-new-york-times-article-on-pbms-1

Client news

READ: Follow up to second New York Times article on PBMs

October 24, 2024

https://primetherapeutics.com/w/read-prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity-1 /prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Client news

READ: Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 23, 2024

Showing 1 to 9 of 39

Categories

CC State Government Solutions

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1 Example Link

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025 Example Link

Client news

READ: Featured Drug Insights: January 2025

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms Example Link

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply Example Link

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024 Example Link

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/read-stars-and-bid-forum-prime-s-medicare-clients-lead-the-way-1 Example Link

Client news

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

December 19, 2024

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy Example Link

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024 Example Link

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

https://primetherapeutics.com/w/introducing-the-2024-medicaid-pharmacy-trend-report- Example Link

Client news

Introducing the 2024 Medicaid Pharmacy Trend Report!

November 21, 2024

Showing 1 to 9 of 46

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Careers

Careers Overview

Client Communications - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Read

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

READ: Severe weather preparedness – wildfires and winter storms

READ: Prime’s response to recent AIDS Healthcare Foundation ruling

READ: FTC second interim report: Key insights and information

READ: FTC second interim report: Key insights and information

The Latest

READ: Prime’s response to recent AIDS Healthcare Foundation ruling

READ: FTC second interim report: Key insights and information

READ: Featured Drug Insights: January 2025

READ: IRA FAQ updates - January 2025

READ: Improved contact center performance this week

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

READ: FTC second interim report: Key insights and information

READ: Featured Drug Insights: January 2025

Updates to GLP-1s and Prime's standard maintenance drug list used by mid-market clients

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

HIPAA privacy rule supports reproductive health care privacy

READ: Featured Drug Insights: November 2024

READ: Prime’s GLP-1 resources page: Prime’s source for everything GLP-1

READ: FTC second interim report: Key insights and information

READ: Featured Drug Insights: January 2025

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

HIPAA privacy rule supports reproductive health care privacy

READ: Featured Drug Insights: November 2024

READ: Prime’s GLP-1 resources page: Prime’s source for everything GLP-1

READ: New Prime brand update

READ: FTC second interim report: Key insights and information

READ: Featured Drug Insights: January 2025

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

READ: Featured Drug Insights: November 2024

READ: Mandatory sensitivity labels begin Nov. 14

READ: Follow up to second New York Times article on PBMs

READ: Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

READ: FTC second interim report: Key insights and information

READ: Featured Drug Insights: January 2025

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

HIPAA privacy rule supports reproductive health care privacy

READ: Featured Drug Insights: November 2024

Introducing the 2024 Medicaid Pharmacy Trend Report!

Login Portals

Compliance / Legal

Careers